<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ratios of young platelets or reticulated platelets can be routinely obtained as an immature platelet fraction (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e>) with the XE-2100 automated hematology analyzer (Sysmex, Kobe, Japan) </plain></SENT>
<SENT sid="1" pm="."><plain>We combined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> analysis of 31 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with a complete blood count, a bone marrow examination, and a chromosome analysis </plain></SENT>
<SENT sid="2" pm="."><plain>The patients with &gt;40 x 10(9)/L platelets were classified as group A, and those with &gt; or =40 x 10(9)/L were placed in group B </plain></SENT>
<SENT sid="3" pm="."><plain>The 2 groups were subclassified as A1 or B1 for patients with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> of &lt;10% and as A2 or B2 for those with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> &gt; or =10% </plain></SENT>
<SENT sid="4" pm="."><plain>Categories A1, A2, B1, and B2 comprised 12 patients, 6 patients, 7 patients, and 6 patients, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with a relatively high <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> (&gt;10%) (category A2 or B2) showed distinctive characteristics </plain></SENT>
<SENT sid="6" pm="."><plain>Group B2 showed a higher frequency of chromosomal abnormalities than B1 (P = .029), and group A2 tended to show a higher incidence of clinical improvement than A1 (P = .08) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IPF</z:e> determination may be clinically useful for the assessment of prognosis for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>